1. Mu, Mingchao, Zhang, Qin, Li, Jing, Sun, Xuejun, Yu, Junhui. 2023. USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A. In Cell death and differentiation, 30, 2393-2407. doi:10.1038/s41418-023-01228-8. https://pubmed.ncbi.nlm.nih.gov/37816999/
2. Sato, Yusuke, Yoshizato, Tetsuichi, Shiraishi, Yuichi, Homma, Yukio, Ogawa, Seishi. 2013. Integrated molecular analysis of clear-cell renal cell carcinoma. In Nature genetics, 45, 860-7. doi:10.1038/ng.2699. https://pubmed.ncbi.nlm.nih.gov/23797736/
3. Andreou, Avgi, Yngvadottir, Bryndis, Bassaganyas, Laia, Snape, Katie, Maher, Eamonn R. . Elongin C (ELOC/TCEB1)-associated von Hippel-Lindau disease. In Human molecular genetics, 31, 2728-2737. doi:10.1093/hmg/ddac066. https://pubmed.ncbi.nlm.nih.gov/35323939/
4. Batavia, Aashil A, Rutishauser, Dorothea, Sobottka, Bettina, Beerenwinkel, Niko, Moch, Holger. 2023. Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity. In Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 36, 100194. doi:10.1016/j.modpat.2023.100194. https://pubmed.ncbi.nlm.nih.gov/37088333/
5. Wang, Yan, Zhao, Peng, Wang, Lili, Zhang, Wei, Jiang, Yanxia. 2022. Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma. In Pathology, research and practice, 235, 153960. doi:10.1016/j.prp.2022.153960. https://pubmed.ncbi.nlm.nih.gov/35653922/
6. Wen, Z, Zhang, W H, Liang, J Y, Wang, Z, Fan, L N. . [Clinicopathological and molecular genetic characteristics of ELOC mutated renal cell carcinoma]. In Zhonghua bing li xue za zhi = Chinese journal of pathology, 52, 1204-1209. doi:10.3760/cma.j.cn112151-20230915-00178. https://pubmed.ncbi.nlm.nih.gov/38058035/
智鼠故事 
